WEBINAR: Corporate & Cultural Convergence in Life Sciences M&A

M&A plays an important role in enabling the life sciences ecosystem and is one of the primary routes by which treatments are acquired, nurtured, and brought to market. But what happens after these deals get done? And how can these transactions be more successful for the buyer and seller?

Join us for a webinar discussion that will share a variety of perspectives on M&A transactions, including buy-side and sell-side considerations and experiences. Our panelists will address:

• Recent findings from a newly published report from Mintz and Mergermarket
  providing insight based on interviews with 100 senior-level US executives about their latest deals as well as data on M&A transactions in the life sciences industry

• Deal drivers in 2020: What is motivating M&A activity now?

• Lessons learned from post-merger integrations and challenges associated with combining organizations

• Avoid post-closing dispute